New antibody for Noradrenaline now available using STAINperfect immunostaining kit

New antibody for Noradrenaline now available

using STAINperfect immunostaining kit

Launch of Explicyte Immuno-Oncology!

ImmuSmol is launching Explicyte Immuno-Oncology: a brand-new range of preclinical services in the field of cancer immunotherapy.

ISTRY 2015 : Congratulations to the winners of our quizz

Back from the 2015 ISTRY conference, we would like to thanks the organizers for this fruitful event and congratulate the winners of our quizz.

ImmuSmol sponsors the 2015 ISTRY conference

ImmuSmol is sponsoring the 2015 conference of the International Society for Tryptophan Research, taking place on September 16-18, at the Van Andel Research Institute in Grand Rapids, Michigan, USA.

New article! Characterization of Kynurenine pathway in human obesity

ImmuSmol CEO Alban Bessede has contributed to a recent paper in Obesity : “The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation.”

L-Kynurenine monoclonal antibody in PLOS ONE

A recent PLOS ONE article shows that ImmuSmol’s anti-L-Kynurenine-antibody can serve to stratify cancer patients for kynurenine pathway activity. Access the article…

The immune-brain axis: from molecules to behavior

ImmuSmol is sponsoring the Symposium “The immune-brain axis: from molecules to behavior”, held at the Hasselt University, Campus Diepenbeek, Belgium, on March 12th and 13th, 2015.

ImmuSmol’s Small Molecule Antibodies in the Press

Discover ImmuSmol’s story, featured in the 2015 winter edition of the European Biotechnology Magazine.

Happy 2015 !

Just a few words to thank our clients and partners and wish them a bright and joyful 2015.

ImmuSmol raises 500 000 € to advance cancer immunotherapy programme

ImmuSmol is pleased to announce it has raised 500 000 € to progress its monoclonal antibodies for cancer immunotherapy to in vivo proof-of-concept (POC).